References
- Ao S., Shingu Y., Notsu Y., Kikuchi C., Yamaguchi I. Characterization of a novel aldose reductase inhibitor, FR74366. Proceedings, Japan-US Aldose Reductase Workshop, N. Sakamoto, J. H. Kinoshita, P. F. Kadorand, N. Hotta. Excerpta Medica, Amsterdam-New York-Oxford 1990; 81–88
- Bosnes R. W., Taussky H. H. The colorimetric determination of creatinine by the Jaffe reaction. Journal of Biological Chemistry 1945; 158: 581–591
- Gregson R. H. S., Hirom P. C., Millburn P., Smith R. L., Turbert H. B., Williams R. T. The biliary excretion of tartrazine, sex differences in the rat and species differences in the rat, guinea-pig and rabbit. Journal of Pharmacy and Pharmacology 1971; 24: 20–24
- Hanhijarvi H., Ophaung R., Singer L. The sex-related difference in perfluorooctanoate excretion in the rat. Proceedings of the Society for Experimental Biology and Medicine 1982; 171: 50–55
- Hasegawa J., Smith P. C., Benet L. Z. Apparent intramolecular acylmigration of zomepirac glucuronide. Drug Metabolism and Disposition 1982; 10: 469–473
- Hewitt W. R., Hook J. B. The renal excretion of drugs. Progress in Drug Metabolism, J. W. Bridges, L. F. Chasseaud. John Wiley & Sons, Chichester 1983; Vol. 7: 11–56
- Horrock D. L., Studier M. H. Two level plutonium-241 analysis by liquid scintillation technique. Analytical Chemistry 1958; 30: 1747–1750
- Janssen F. W., Young E. M., Ruelius H. W. Effect of sex hormones on the disposition in rats of 1-aminocyclohexane carboxylic acid, a metabolite of a semisynthetic penicillin. Drug Metabolism and Disposition 1976; 6: 540–546
- Kanamaru M., Mizuno A., Nagashima S., Uematsu J., Nakashima M., Terakawa M., Sugiyama A. Pharmacokinetics of FK366and its effect on aldose reductase and serum uric acid in healthy volunteers. European Journal of Clinical Pharmacology 1989; 36: A315, Suppl.
- Kato R. Sex-related differences in drug metabolism. Drug Metabolism Reviews 1974; 3: 1–32
- Mulder G., Wierckx F., Jansen P., Warrander A. Acylglucuronidation of Ponalrestat in the rat in vivo and its role in the sex difference in urinary excretion of the drug. Cellular and Molecular Aspects of Glucuronidation Collogue INSERM 1988; 173: 271–278
- Shah V. P., Wallace S. M., Reigeiman S. Microultrafiltration technique for drug-protein binding determination in plasma. Journal of Pharmaceutical Science 1974; 63: 1364–1367
- Tanaka Y., Ishi I., Deguchi Y., Terai T., Tokuma Y., Noda K. The metabolism of FR74366, aldose reductase inhibitor. I: Sex differences in the rat. Xenobiotic Metabolism and Disposition 1990; 5: 67
- Tanaka Y., Sekiguchi M., Sawamoto T., Tokuma Y., Noda K. Drug metabolism of ARI, FR74366 in the rat and dog, in Proceedings. Annual Meeting of the Pharmaceutical Society of Japan 1991; 14: 134
- Tokuma Y., Ishi I., Hashimoto T., Tanaka Y., Noda K. The metabolism of FR74366, aldose reductase inhibitor. II: Isolation, identification and stability of FR74366–1-O-acylglucuronide. Xenobiotic Metabolism and Disposition 1990; 5: 68
- Weiner I. M., Mudge G. H. Renal tubular mechanisms for excretion of organic acids and bases. American Journal of Medicine 1964; 36: 743–762